Easy assessment of the avidity of polyclonal allergen‐specific serum antibodies
Clinical & Experimental Allergy · 2024
DOI: 10.1111/cea.14448 ↗At a glance
Journal article in Clinical & Experimental Allergy, 2024. Written by Maria R Strobl and 5 co-authors. Institution: Center for Pathophysiology, Infectiology and Immunology, Institute of Pathophysiology and Allergy Research, Medical University of Vienna, Vienna, Aus…. Major MEDLINE topics: Immunoglobulin E, Hypersensitivity. Cited 4 times so far (Crossref); 23 references. The full text is freely available (open access, CC BY 4.0). Funded by: Austrian Science Fund FWF, Medizinische Universität Wien, Austrian Science Fund.
Abstract (original language)
Introduction
Allergen‐specific IgE‐blocking IgG antibodies contribute to successful allergen immunotherapy (AIT), however, not much is known about their affinity. Since affinity measurements of polyclonal antibodies in serum are technically challenging we evaluated the applicability of acidic disruption of antibody‐allergen complexes by a modified ELISA protocol with monoclonal antibodies (mAbs) specific for the relevant major allergens Betv1 and Mald1. Then, AIT‐induced blocking and non‐blocking Mald1‐specific antibodies in sera from individuals with or without reduced apple allergy were compared.
Methods
After testing their pH stability coated recombinant allergens were incubated with (i) mAbs diluted in PBS or human serum and (ii) sera from individuals after sublingual administration of Mald1 or Betv1 for 16 weeks. Immune complexes were exposed to buffers in the pH range of 6.4–3.4 and residual antibodies were measured. Avidity indexes (AI), defined as the pH removing 50% of antibodies, were compared to the dissociation constants ( K D ) of mAbs determined by surface plasmon resonance.
Results
The selected pH range was applicable to disrupt allergen complexes with highly affine mAbs without compromising allergen integrity. AIs of mAbs accorded with K D values and were unaffected by epitope specificity or the presence of serum proteins. The inter‐assay variability was
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Center for Pathophysiology, Infectiology and Immunology, Institute of Pathophysiology and Allergy Research, Medical University of Vienna, Vienna, Austria.
- Department of Biotechnology, Institute of Molecular Biotechnology, University of Natural Resources and Life Sciences (BOKU), Vienna, Austria.
- Molecular Allergology, Paul-Ehrlich-Institute, Langen, Germany.
ORCID profiles: Andrea Wangorsch, Barbara Bohle
Funding
- Austrian Science Fund FWF
- Medizinische Universität Wien
- Austrian Science Fund
- Danube Allergy Research Cluster
Cite
APA
Strobl, M. R., Demir, H., Wozniak-Knopp, G., Wangorsch, A., Rüker, F., & Bohle, B. (2024). Easy assessment of the avidity of polyclonal allergen‐specific serum antibodies. Clinical & Experimental Allergy. https://doi.org/10.1111/cea.14448
Vancouver
Strobl MR, Demir H, Wozniak-Knopp G, Wangorsch A, Rüker F, Bohle B. Easy assessment of the avidity of polyclonal allergen‐specific serum antibodies. Clinical & Experimental Allergy. 2024. doi:10.1111/cea.14448
BibTeX
@article{Strobl2024,
author = {Strobl, Maria R and Demir, Hilal and Wozniak-Knopp, Gordana and Wangorsch, Andrea and Rüker, Florian and Bohle, Barbara},
title = {Easy assessment of the avidity of polyclonal allergen‐specific serum antibodies},
journal = {Clinical & Experimental Allergy},
year = {2024},
doi = {10.1111/cea.14448}
}
EUVIMED